Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$8.04 - $11.87 $24,988 - $36,891
3,108 Added 47.82%
9,608 $86.8 Million
Q1 2024

May 15, 2024

BUY
$6.73 - $12.2 $3,365 - $6,100
500 Added 8.33%
6,500 $73.5 Million
Q4 2023

Feb 14, 2024

BUY
$5.52 - $8.03 $33,120 - $48,179
6,000 New
6,000 $47.8 Million

Others Institutions Holding CNTA

About Centessa Pharmaceuticals plc


  • Ticker CNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,339,296
  • Market Cap $1.65B
  • Description
  • Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...
More about CNTA
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.